All Stories

  1. Evaluating ivosidenib for the treatment of relapsed/refractory AML: design, development, and place in therapy

    Article • OncoTargets and Therapy, December 2018, Dove Medical Press

    Imad Tabbara, Coen Lap, Dr Samah Nassereddine